Skip to the guide
Baltimore care field guideEvidence brief

Evidence brief / read the label

Evidence behind a Baltimore peptide doctor offer

FDA approval, a registered facility, a medicine mixed to order, and a code in a government list are four different things. None is a higher or lower grade of another. Each answers its own question.

Three routes

The evidence changes with the product

As of September 2026, “peptide” was only a chemistry word; U.S. law had no special category or rulebook for peptides.

Approved product

As of September 2026, FDA approval applied to a named drug product, form, and set of uses reviewed by the agency.

Compounded preparation

As of September 2026, compounding could meet a patient need, but the finished medicine was not FDA-approved or reviewed before sale.

Unapproved chemical

As of September 2026, a “research use” label did not make the sale of an unapproved treatment lawful.

Made-to-order medicine

Two compounding paths, two kinds of oversight

Regular pharmacy path

As of September 2026, a regular pharmacy that mixes medicine to order, called a 503A pharmacy after a section of the drug law, generally prepared each medicine for a single named patient who had a prescription.

As of September 2026, state pharmacy boards handled most daily oversight.

Outsourcing facility path

As of September 2026, a bigger plant called a 503B outsourcing facility, which often supplies clinics and hospitals, could make larger germ-free batches without a prescription carrying your name.

As of September 2026, it was bound by the same manufacturing quality rules as drug factories, and FDA inspected it.

An inspection means FDA looked at the plant. It is not approval of the medicine.

Registered does not mean approved

As of September 2026, registering as an outsourcing facility was not FDA approval of the facility or its products.

Codes and lists

A code can identify a listing without approving it

As of September 2026, an NDC, the National Drug Code number given to a listed drug product, or a place in the federal drug directory did not show that FDA had approved a product.

The listing information comes from the company. Read the approval record, not the presence of a code.

Where to check this

The licence checks page links to FDA’s list of registered outsourcing facilities and its plain guide to compounding.

A registration or a code can be real and still not mean what the sales page suggests. As of September 2026, registration showed registration, and a code showed a listing; neither alone showed approval.

Next: check the records yourself

The licence checks page links to Maryland and federal search tools.

Open the licence checks